CannabisNewsWire Editorial Coverage: Out of 120 applicants, Manitoba recently awarded four master retail licenses, a monumental action as Canada prepares to legalize cannabis for recreational use this summer. The entities that now hold prized licenses to retail pot and its associated paraphernalia in the province are: Tokyo Smoke, a subsidiary of HIKU Brands (CSE:HIKU; OTCBB: … Continue reading “Key Companies That Will Remap Canada’s Cannabis Retail Industry”
Related Editorial Investors seeking opportunities in the cannabis market may want to turn their attention toward companies offering solutions for a situation that could otherwise slow the industry’s growth. A number of emerging firms are providing or pursuing payment options that can help cannabis companies sidestep the roadblock created by the lack of access to … Continue reading “CannabisNewsAudio – Opportunity Amid Cannabis Banking Hurdles”
CannabisNewsWire Editorial Coverage: Investors seeking opportunities in the cannabis market may want to turn their attention toward companies offering solutions for a situation that could otherwise slow the industry’s growth. A number of emerging firms are providing or pursuing payment options that can help cannabis companies sidestep the roadblock created by the lack of access … Continue reading “Opportunity Amid Cannabis Banking Hurdles”
Company has developed and licensed novel drug delivery systems and products for over 15 years With 14 patents, Skinvisible has proven efficacy and global reach Proposed merger may transform non-opioid pain market At the cutting edge of innovative drug delivery technology since 1999, Skinvisible, Inc. (OTCQB: SKVI), in a recently announced Letter of Intent of … Continue reading “Proposed Merger Expands Skinvisible, Inc. (SKVI) Horizons into Multi-Billion Dollar Pain Market”
Cannabis industry pioneer Cannabiniers will distribute treatments utilizing Invisicare®, a patented polymer delivery system Agreement marks continued growth for Skinvisible’s subsidiary Ovation Science Inc. Patented delivery technology enables improved controlled release of topically applied products Research and development company Skinvisible, Inc. (OTCQB: SKVI) has announced that its subsidiary Ovation Science Inc. has forged a definitive … Continue reading “New Exclusive Licensing Agreement with Cannabiniers, Conducted via Lighthouse Strategies with Skinvisible (SKVI) Subsidiary”
Targeting unmet medical needs with proprietary topical formulations License-based business model translates to worldwide opportunities Patented Invisicare™ technology offers enhanced drug delivery system Global skincare market projected to reach $135 billion by 2021 Research and development company Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI), continues to add significant value to its core business model with several key … Continue reading “Skinvisible, Inc. (SKVI) Maximizes Product Development Opportunities with Global Goals”
Announces formation of new Canadian subsidiary Ovation Science Inc. Agreement forged with Lighthouse Strategies, LLC, regarding exclusive use of patented topical and transdermal formulations in select U.S. markets Licensing agreement recently made with Canopy Growth Corp. for exclusive rights in Canada Research and development company Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) announced on November 16 that … Continue reading “Skinvisible, Inc. (SKVI) Subsidiary Inks License Agreement for US Distribution of Topical Cannabis Products”
Skinvisible, Inc.’s (OTCQB: SKVI) proprietary topical drug delivery technology, Invisicare®, improves the delivery of pharmaceutical and medicinal compounds to and through the skin. The company develops hemp-based products and recently expanded its product line to the enter the cannabis-based topical product market. An article discussing this reads: “The patented polymer technology has been used in … Continue reading “CannabisNewsBreaks – Skinvisible, Inc. (SKVI) Develops Hemp-based Products with an Enhanced Delivery System”
Skinvisible already develops hemp-based products and is expanding its product line of cannabis-based topical product market Research verifies its Invisicare® technology improves the penetration rate and boosts the availability of the cannabis ingredients in both topical and transdermal products Skinvisible has entered a strategic partnership with Canopy Growth Corporation for the sale of its product … Continue reading “Skinvisible, Inc.’s (SKVI) Patented Polymer Delivery Technology Could Take CBD Products to the Next Level”
Owns patented Invisicare® polymer delivery system, prescription and over-the-counter skincare products formulated with Invisicare Business model to grow globally by out-licensing its proprietary and patented product line Developed multiple cannabis-based products with CBD from imported hemp (non-psychoactive), and will continue to develop line utilizing CBD and THC from marijuana Skinvisible, Inc. (OTCQB: SKVI) is targeting … Continue reading “Skinvisible, Inc. (SKVI) Targets Global Skincare Market Projected to Reach $135B by 2021”
